» Articles » PMID: 24980212

Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More Than Coincidence

Overview
Publisher Current Science
Date 2014 Jul 2
PMID 24980212
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure and COPD are very common in the elderly. As both syndromes share common risk factors, such as tobacco smoking, and pathophysiological pathways, including systemic inflammation and activation of the neurohumoral system, they frequently coincide. Because of the similar clinical presentation, diagnoses of COPD in the presence of heart failure may be difficult. If spirometry is performed, caution should be taken in the interpretation of the data, as heart failure by itself (in the absence of true COPD) may exert restrictive as well as obstructive alterations in pulmonary function testing. Once COPD is established, concurrent heart failure may impact on the accurate management of these patients as severity grading of COPD could easily be overrated, and thus there is a risk of overuse of pulmonary medication, with the risk of causing cardiac side-effects. The present review focuses on the pathophysiological interrelation of comorbid COPD and heart failure, and provides practical help on how to deal with both diseases in daily practice.

Citing Articles

Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.

Eckhardt C, Balte P, Barr R, Bertoni A, Bhatt S, Cuttica M Eur Heart J. 2022; 43(23):2196-2208.

PMID: 35467708 PMC: 9631233. DOI: 10.1093/eurheartj/ehac205.


Responses to incremental exercise and the impact of the coexistence of HF and COPD on exercise capacity: a follow-up study.

Dos Santos P, Simoes R, Goulart C, Areas G, Marinho R, Camargo P Sci Rep. 2022; 12(1):1592.

PMID: 35102201 PMC: 8803920. DOI: 10.1038/s41598-022-05503-5.


Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.

Yeoh S, Dewan P, Serenelli M, Ferreira J, Pitt B, Swedberg K Eur J Heart Fail. 2021; 24(3):529-538.

PMID: 34536265 PMC: 10654446. DOI: 10.1002/ejhf.2350.


Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases.

Deshmukh K, Khanna A Tuberc Respir Dis (Seoul). 2020; 84(1):35-45.

PMID: 33045814 PMC: 7801809. DOI: 10.4046/trd.2020.0088.


[Dyspnea : A challenging symptom in the primary care setting].

Frohlich G, Schorn K, Frohlich H Internist (Berl). 2020; 61(1):21-35.

PMID: 31889210 DOI: 10.1007/s00108-019-00720-z.


References
1.
Sin D, Paul Man S . Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107(11):1514-9. DOI: 10.1161/01.cir.0000056767.69054.b3. View

2.
Guazzi M . Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest. 2003; 124(3):1090-102. DOI: 10.1378/chest.124.3.1090. View

3.
Dong Y, Lin H, Shau W, Wu Y, Chang C, Lai M . Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials. Thorax. 2012; 68(1):48-56. DOI: 10.1136/thoraxjnl-2012-201926. View

4.
Mortensen E, Copeland L, Pugh M, Restrepo M, Malo de Molina R, Nakashima B . Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res. 2009; 10:45. PMC: 2697974. DOI: 10.1186/1465-9921-10-45. View

5.
Karabis A, Lindner L, Mocarski M, Huisman E, Greening A . Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis. Int J Chron Obstruct Pulmon Dis. 2013; 8:405-23. PMC: 3772873. DOI: 10.2147/COPD.S48967. View